|
Dr. Carpenter is Founder, President and CEO of Seaside Therapeutics, a drug discovery company focused on developing novel therapeutics for disorders of brain development such as Fragile X and autism.Dr. Carpenter has over 25 years experience in medicine, basic science and clinical research, pharmaceutical drug development and management. He has held a number of leadership positions in the pharmaceutical and biotechnology industries including: President and CEO of Sention, Vice-President of Clinical Research & Development and Regulatory Affairs at Adolor Corporation, Director of Clinical Research at Astra USA, and Member of the Global Therapeutic Area Team at Astra Pain Control Sweden.Dr. Carpenter has broad experience leading pharmaceutical research and development teams submitting a number of successful IND�s, NDA�s and sNDA�s.Prior to industry, Dr. Carpenter held academic faculty appointments at the University of Washington and Wake Forest University. Dr. Carpenter has co-authored 65 journal articles and seven patents and has served as editor-in-chief or on the editorial boards of four medical journals.He has frequently been an invited speaker at national and international meetings and symposia and has been an invited visiting professor to numerous domestic and international universities and medical schools.Dr. Carpenter is Board Certified in Anesthesiology and Pain Management, completed a fellowship in pharmacokinetics at the University of California San Francisco and a sabbatical in molecular biology at the University of Washington. | 